Literature DB >> 23926131

Hypertension in an experimental model of systemic lupus erythematosus occurs independently of the renal nerves.

Keisa W Mathis1, Marcia Venegas-Pont, Elizabeth R Flynn, Jan Michael Williams, Christine Maric-Bilkan, Terry M Dwyer, Michael J Ryan.   

Abstract

Systemic lupus erythematosus (SLE) is a chronic inflammatory disorder with prevalent hypertension and renal injury. In this study, we tested whether the renal nerves contribute to the development of hypertension in an established mouse model of SLE (NZBWF1). Female SLE and control (NZW/LacJ) mice were subjected to either bilateral renal denervation or a sham procedure at 32 wk of age. Two weeks later, blood pressure was assessed in conscious mice using carotid artery catheters. Blood pressure was higher in SLE mice compared with controls, as previously reported; however, blood pressure was not altered in the denervated SLE or control mice. The development of albuminuria was markedly blunted in denervated SLE mice; however, glomerulosclerosis was increased. Renal denervation reduced renal cortical expression of monocyte-chemoattractant protein in SLE mice but did not significantly alter renal monocyte/macrophage infiltration. Renal cortical TNF-α expression was also increased in sham SLE mice, but this was not impacted by denervation. This study suggests that the renal nerves do not have a significant role in the pathogenesis of hypertension, but have a complex effect on the associated renal inflammation and renal injury.

Entities:  

Keywords:  albuminuria; blood pressure; immune; inflammation; renal injury

Mesh:

Substances:

Year:  2013        PMID: 23926131      PMCID: PMC3798797          DOI: 10.1152/ajpregu.00602.2012

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  47 in total

1.  Intrarenal handling of proteins in rats using fractional micropuncture technique.

Authors:  A Tojo; H Endou
Journal:  Am J Physiol       Date:  1992-10

2.  Renal nerve activity does not contribute to the development of renovascular hypertension in rats with abdominal aortic constriction.

Authors:  A C Eklöf; T Hökflet; A Aperia
Journal:  Acta Physiol Scand       Date:  1991-01

3.  Renal denervation attenuates the sodium retention and hypertension associated with obesity.

Authors:  S Kassab; T Kato; F C Wilkins; R Chen; J E Hall; J P Granger
Journal:  Hypertension       Date:  1995-04       Impact factor: 10.190

4.  Interleukin-4 promotes the expansion of skin-infiltrating lymphocytes from atopic dermatitis in vitro.

Authors:  U Reinhold; S Kukel; B Goeden; U Neumann; W Wehrmann; H W Kreysel
Journal:  J Invest Dermatol       Date:  1991-03       Impact factor: 8.551

5.  Differences in the occurrence of hypertension among (NZB X NZW)F1, MRL-lpr, and BXSB mice with lupus nephritis.

Authors:  U H Rudofsky; R L Dilwith; J B Roths; D A Lawrence; V E Kelley; A M Magro
Journal:  Am J Pathol       Date:  1984-07       Impact factor: 4.307

Review 6.  Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease.

Authors:  D T Boumpas; H A Austin; B J Fessler; J E Balow; J H Klippel; M D Lockshin
Journal:  Ann Intern Med       Date:  1995-06-15       Impact factor: 25.391

7.  Renal sensory and sympathetic nerves reinnervate the kidney in a similar time-dependent fashion after renal denervation in rats.

Authors:  Jan Mulder; Tomas Hökfelt; Mark M Knuepfer; Ulla C Kopp
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-13       Impact factor: 3.619

8.  Effect of a specific endothelin A receptor antagonist on murine lupus nephritis.

Authors:  T Nakamura; I Ebihara; Y Tomino; H Koide
Journal:  Kidney Int       Date:  1995-02       Impact factor: 10.612

9.  Effect of captopril on murine systemic lupus erythematosus disease.

Authors:  H Herlitz; C Svalander; A Tarkowski; G Westberg
Journal:  J Hypertens Suppl       Date:  1988-12

10.  Role of renal nerves in mediating the hypertensive effects of nitric oxide synthesis inhibition.

Authors:  J Granger; J Novak; C Schnackenberg; S Williams; G A Reinhart
Journal:  Hypertension       Date:  1996-03       Impact factor: 10.190

View more
  27 in total

1.  Anti-CD3 antibody therapy attenuates the progression of hypertension in female mice with systemic lupus erythematosus.

Authors:  Keisa W Mathis; Erin B Taylor; Michael J Ryan
Journal:  Pharmacol Res       Date:  2017-04-08       Impact factor: 7.658

2.  Renal Denervation Prevents Immune Cell Activation and Renal Inflammation in Angiotensin II-Induced Hypertension.

Authors:  Liang Xiao; Annet Kirabo; Jing Wu; Mohamed A Saleh; Linjue Zhu; Feng Wang; Takamune Takahashi; Roxana Loperena; Jason D Foss; Raymond L Mernaugh; Wei Chen; Jackson Roberts; John W Osborn; Hana A Itani; David G Harrison
Journal:  Circ Res       Date:  2015-07-08       Impact factor: 17.367

3.  Preventing autoimmunity protects against the development of hypertension and renal injury.

Authors:  Keisa W Mathis; Kedra Wallace; Elizabeth R Flynn; Christine Maric-Bilkan; Babbette LaMarca; Michael J Ryan
Journal:  Hypertension       Date:  2014-07-14       Impact factor: 10.190

Review 4.  The immune system and hypertension.

Authors:  Madhu V Singh; Mark W Chapleau; Sailesh C Harwani; Francois M Abboud
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

5.  Expansion of regulatory T cells using low-dose interleukin-2 attenuates hypertension in an experimental model of systemic lupus erythematosus.

Authors:  Erin B Taylor; Jennifer M Sasser; Kenji J Maeda; Michael J Ryan
Journal:  Am J Physiol Renal Physiol       Date:  2019-03-20

Review 6.  Crosstalk between the nervous system and the kidney.

Authors:  Shinji Tanaka; Mark D Okusa
Journal:  Kidney Int       Date:  2019-11-22       Impact factor: 10.612

7.  Targeted afferent renal denervation reduces arterial pressure but not renal inflammation in established DOCA-salt hypertension in the rat.

Authors:  Christopher T Banek; Madeline M Gauthier; Daniel C Baumann; Dusty Van Helden; Ninitha Asirvatham-Jeyaraj; Angela Panoskaltsis-Mortari; Gregory D Fink; John W Osborn
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-03-07       Impact factor: 3.619

Review 8.  AKI and the Neuroimmune Axis.

Authors:  Shinji Tanaka; Mark D Okusa
Journal:  Semin Nephrol       Date:  2019-01       Impact factor: 5.299

9.  Plasma Cell Depletion Attenuates Hypertension in an Experimental Model of Autoimmune Disease.

Authors:  Erin B Taylor; Michelle T Barati; David W Powell; Hannah R Turbeville; Michael J Ryan
Journal:  Hypertension       Date:  2018-01-29       Impact factor: 10.190

10.  17β-Estradiol protects against the progression of hypertension during adulthood in a mouse model of systemic lupus erythematosus.

Authors:  Emily L Gilbert; Keisa W Mathis; Michael J Ryan
Journal:  Hypertension       Date:  2013-12-23       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.